| Literature DB >> 24022763 |
Cristiane B de Oliveira1, Lucimara N Comunello, Erica S Maciel, Scheron R Giubel, Alessandra N Bruno, Eduardo C F Chiela, Guido Lenz, Simone C B Gnoatto, Andréia Buffon, Grace Gosmann.
Abstract
Baccharis trimera is used in folk medicine as a tea for digestive and liver diseases. It possesses anti-inflammatory and antioxidant properties that are related to the presence of phenolic compounds. The aim of this work was to investigate the anti-proliferative properties of phenolic (PHE) and terpenoid (SAP) compounds from B. trimera on human cervical cancer. The treatment of SiHa cells with PHE for 24 h suppressed colony formation in a dose-dependent manner, inhibited proliferation and inhibited cell motility. Although SAP inhibited the proliferation of SiHa cells in a dose-dependent manner, it increased colony formation and did not inhibit cell motility. PHE and SAP also promoted a significant increase in lactate dehydrogenase levels in the culture medium in a dose-dependent manner, indicating a loss of cell membrane integrity. Moreover, PHE promoted necrotic cell death, whereas SAP induced apoptosis. These compounds are new anticancer prototypes due their significant anticancer activity demonstrated herein.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24022763 PMCID: PMC6270023 DOI: 10.3390/molecules180911022
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1SiHa cell viability effects. (A) The cells were incubated with PHE or SAP for 24 h; (B) Cell counts after treatment with PHE or SAP for 24 h; (C) Loss of membrane integrity measured by LDH release after treatment with PHE or SAP for 24 h. All values are the means ± SE of at least triplicate cultures in four independent experiments (* p < 0.05 as compared to the control and ** p < 0.05 compared to cisplatin (CIS) 50 µM).
Figure 2Effects on the clonogenic potential of tumor cells after exposure to 200 µg/mL of PHE or SAP. (A) Colonies formed after 24 h of treatment with PHE or SAP; 88 colonies were formed by untreated cells. After PHE treatment, 10 colonies formed; after SAP treatment, 135 colonies formed; (B) All values are the means ± SE of at least triplicate cultures in four independent experiments (p < 0.05 compared with the control).
Figure 3Wound-healing assay after treatment with the IC50 concentration of PHE (482 µg/mL) or SAP (456 µg/mL) for 24 h. (A) Confluent cultured cells were carefully wounded, incubated in RPMI serum-free medium and treated with or without compounds for 24 h, and the complete medium was then replaced. Cells were photographed using an inverted microscope at the indicated times; (B) Distance of migrated cells (% Control). All values are the means ± SE of at least triplicate cultures in four independent experiments (p < 0.05 compared with the control at 0 h and 48 h).
Figure 4(A) Scatter plots of annexin-V-FITC/PI stained control cells and cells treated with PHE or SAP categorized by quadrant analysis. UL (upper left) early apoptotic cells, UR (upper right) late apoptotic cells, LL (lower left) normal cells and LR (lower right) necrotic cells. Triton X-100 (TX100) was used as necrosis positive control and Cisplatin was used as apoptosis positive control; (B) The data are representative of four independent experiments. All values are the means ± SE of at least triplicate cultures in four independent experiments (* p < 0.05 and ** p < 0.01 compared with the control).